Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,907,640 shares of BIO stock, worth $617 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,907,640
Previous 2,374,507
19.66%
Holding current value
$617 Million
Previous $649 Million
1.58%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Black Rock Inc. New York, NY1.55MShares$502 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$422 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$352 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$231 Million0.5% of portfolio
-
Select Equity Group, L.P. New York, NY708KShares$229 Million0.95% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.97B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...